Sign in to continue:

Saturday, March 14th, 2026

MultiSensor AI Holdings, Inc. Announces $60 Million At Market Issuance Sales Agreement with Roth Capital Partners and H.C. Wainwright





MultiSensor AI Holdings, Inc. – At Market Issuance Sales Agreement Announcement

MultiSensor AI Holdings, Inc. Announces At Market Issuance Sales Agreement for Up to \$60 Million

Key Highlights

  • At Market Issuance Sales Agreement signed: MultiSensor AI Holdings, Inc. (NASDAQ: MSAI) has entered into an At Market Issuance Sales Agreement, allowing the company to offer and sell up to \$60,000,000 of common stock from time to time through Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC as sales agents or principals.
  • Potential dilution and capital raise: The company may issue new shares in the open market, which could impact current shareholders through dilution but also provides flexibility to strengthen the balance sheet and fund growth initiatives.
  • Legal and regulatory compliance: The shares will be issued under the company’s shelf registration statement on Form S-3 (File No. 333-284437), declared effective by the SEC on January 30, 2025, ensuring the offering is registered and compliant with SEC regulations.
  • Amendment to Securities Purchase Agreement: On March 12, 2026, MultiSensor AI Holdings, Inc. and certain investors amended the October 24, 2025 Securities Purchase Agreement to permit the at-market offering, removing potential contractual barriers to the new capital raise.
  • Emerging Growth Company status: The company confirmed it is an emerging growth company, which provides some leeway in applying certain accounting and disclosure standards.
  • NASDAQ listing maintained: The common stock (trading symbol: MSAI) and warrants (trading symbol: MSAIW) remain listed on the NASDAQ Stock Market LLC, and there is no current indication of delisting or trading suspension.

Details of the At Market Sales Agreement

On March 13, 2026, MultiSensor AI Holdings, Inc. entered into a significant agreement with Roth Capital Partners, LLC and H.C. Wainwright & Co., LLC. This At Market Issuance Sales Agreement enables the company to offer and sell up to \$60 million of its common stock at prevailing market prices. The sales will be made through “at the market” offerings as defined in Rule 415 under the Securities Act of 1933. Sales, if any, will be conducted using a prospectus supplement dated March 13, 2026, and an accompanying base prospectus dated January 30, 2025.

The base prospectus and supplement are part of the company’s effective shelf registration, providing the legal framework and transparency required by the SEC. The company filed the relevant exhibits (the full sales agreement and legal opinions) as part of its Form 8-K for investor review.

Potential Impact on Shareholders and Share Price

  • Potential Dilution: This agreement allows the company to issue additional shares, which could dilute existing shareholders’ ownership. However, the flexibility provides the company with a tool to raise capital efficiently, potentially funding future growth, strategic investments, or operational needs.
  • Price Sensitivity: The announcement of a large at-market program can sometimes pressure the share price in the short term due to dilution concerns. However, investors may also see this as a positive if they believe the capital raised will be deployed in value-enhancing initiatives.
  • Regulatory and Good Governance: The company provided legal opinions and confirmed compliance with all relevant SEC rules and NASDAQ requirements. As an emerging growth company, MultiSensor AI Holdings, Inc. may utilize certain reduced disclosure requirements, which could affect the depth of available financial information for investors.
  • No Current Material Adverse Events: The company represented that since December 31, 2025, there have been no material adverse effects, no default on debt, and no proceedings or investigations that would materially impact the business or its ability to conduct this offering.
  • Transparency and Controls: Internal controls over financial reporting and disclosure controls have been evaluated as effective, and there have been no significant changes since the last evaluation date. The company also affirms Sarbanes-Oxley compliance and no material weaknesses in controls.
  • Use of Proceeds: The company stated it will use net proceeds from any at-market sales as described in the prospectus supplement under the “Use of Proceeds” section, which typically includes general corporate purposes, working capital, or strategic investments.
  • No Manipulation or Stabilization: The company made explicit representations that it will not engage in any market manipulation or stabilization activities in connection with this offering.

Other Noteworthy Details

  • Legal Opinions Filed: Haynes and Boone, LLP, filed a legal opinion regarding the validity of the shares to be issued under this agreement, further ensuring regulatory compliance.
  • No Offer or Solicitation Outside Registration: The company emphasized that this disclosure is not an offer to sell or the solicitation of offers to buy the securities in any jurisdiction where such offers or sales are not permitted.
  • Reporting and Disclosure: The company will provide all required reports and filings to the SEC and NASDAQ, and will furnish agents and investors with all relevant disclosures for transparency.

Conclusion

Investor Takeaway: MultiSensor AI Holdings, Inc.’s new At Market Issuance Sales Agreement provides the company with the flexibility to raise up to \$60 million in primary capital through the sale of common shares on the open market. This move is significant and may be price sensitive due to the potential for dilution and the impact on supply and demand for MSAI shares. However, it also positions the company to capitalize on future opportunities and strengthen its balance sheet. Shareholders are advised to monitor future announcements regarding the actual sales made under this agreement and the use of proceeds.


Disclaimer: The information provided above is a summary and interpretation of MultiSensor AI Holdings, Inc.’s Form 8-K and related exhibits, intended for informational purposes only. This article does not constitute investment advice. Investors should review the full SEC filings and consult their financial advisors before making investment decisions. The company’s future performance and share price may be affected by a variety of factors, including those discussed above and in its public filings.




View MultiSensor AI Holdings, Inc. Historical chart here



Werewolf Therapeutics Explores Strategic Alternatives Including Sale, Merger, or Partnerships to Maximize Stockholder Value

Werewolf Therapeutics Initiates Review of Strategic Alternat...

Pulmonx Corporation 2025 Annual Report: Innovative COPD Solutions, Zephyr Valve Clinical Data, and Global Market Strategy

Pulmonx Corporation 2025 Annual Report – Key Investor Takeaw...

Valero Energy Corporation Announces $850 Million 5.150% Senior Notes Offering Due 2036

Valero Energy Corporation Announces \$850 Million Senior Not...

   Ad